160 related articles for article (PubMed ID: 1976339)
1. Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol.
Vigholt-Sørensen E; Faergeman O
Br Heart J; 1990 Sep; 64(3):186-9. PubMed ID: 1976339
[TBL] [Abstract][Full Text] [Related]
2. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group.
Lancet; 1988 Mar; 1(8584):489-93. PubMed ID: 2893916
[TBL] [Abstract][Full Text] [Related]
3. Effects of xamoterol, a beta 1 adrenoceptor partial agonist, in patients with ischaemic dysfunction of the left ventricle.
Vigholt-Sørensen E; Faergeman O; Snow HM
Br Heart J; 1989 Nov; 62(5):335-41. PubMed ID: 2574049
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of xamoterol (a beta 1-adrenoceptor partial agonist) in patients with mild to moderate heart failure.
Sørensen EV; Faergeman O; Day MA; Snow HM
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):86S-88S. PubMed ID: 2572265
[TBL] [Abstract][Full Text] [Related]
5. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.
Lancet; 1990 Jul; 336(8706):1-6. PubMed ID: 1694945
[TBL] [Abstract][Full Text] [Related]
6. Xamoterol, a beta 1-adrenoceptor partial agonist: review of the clinical efficacy in heart failure.
Marlow HF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):23S-30S. PubMed ID: 2572251
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of xamoterol, a beta 1-adrenoceptor partial agonist, in mild to moderate heart failure. U.K. Xamoterol Study Group.
Waller DG; Webster J; Sykes CA; Bhalla KK; Wray R
Eur Heart J; 1989 Nov; 10(11):1003-10. PubMed ID: 2574108
[TBL] [Abstract][Full Text] [Related]
8. Xamoterol in severe congestive heart failure: long-term oral treatment, a double-blind randomised study.
Tangø M; Lyngborg K; Mehlsen J; Svendsen TL; Trap-Jensen J
Int J Cardiol; 1992 Jan; 34(1):63-8. PubMed ID: 1347763
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure.
Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK
Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587
[TBL] [Abstract][Full Text] [Related]
10. Xamoterol in mild to moderate heart failure: a subgroup analysis of patients with cardiomegaly but no concomitant angina pectoris.
European 'Corwin' Study Group
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):67S-69S. PubMed ID: 2572258
[TBL] [Abstract][Full Text] [Related]
11. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
Erlemeier HH; Kupper W; Bleifeld W
Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
[TBL] [Abstract][Full Text] [Related]
12. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
de Feyter PJ; Serruys PW; Suryapranata H
Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562
[TBL] [Abstract][Full Text] [Related]
13. Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study.
Sorensen EV; Sterndorff B; Andersen MF; Faergeman O
Cardiovasc Drugs Ther; 1989 Apr; 3(2):203-9. PubMed ID: 2577283
[TBL] [Abstract][Full Text] [Related]
14. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Virk SJ; Davies MK
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
[TBL] [Abstract][Full Text] [Related]
15. Long-term studies with xamoterol in heart failure.
Waller DG
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):53S-58S. PubMed ID: 2572255
[TBL] [Abstract][Full Text] [Related]
16. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
Heng MK
Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitors.
Pouleur H; Hanet C; Rousseau MF
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):82S-83S. PubMed ID: 2572263
[TBL] [Abstract][Full Text] [Related]
18. Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
Marlow HF
Circulation; 1990 Feb; 81(2 Suppl):III93-8. PubMed ID: 1967561
[TBL] [Abstract][Full Text] [Related]
19. [The value of xamoterol in moderate ischemic cardiac insufficiency].
Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
Pouleur H; Hanet C; Rousseau MF
Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
